USARx offers multiple ways to purchase this medication. Choose the Best option for you!
Note: This document contains side effect information about betamethasone topical. Some of the dosage forms listed on this page may not apply to the brand name Diprolene.
Applies to betamethasone topical: topical application cream, topical application lotion, topical application ointment, topical application spray
Other dosage forms:
Along with its needed effects, betamethasone topical (the active ingredient contained in Diprolene) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking betamethasone topical:
Incidence not known
Some side effects of betamethasone topical may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence not known
Applies to betamethasone topical: topical cream, topical foam, topical gel, topical lotion, topical ointment, topical spray
The most commonly reported side effects were pruritus, burning, itching, irritation.
Rare (less than 0.1%): Hypersensitivity
Frequency not reported: Cushing's syndrome
Common (1% to 10%): Pruritus
Uncommon (0.1% to 1%): Folliculitis, skin infections (including bacterial, fungal and viral skin infections)
Frequency not reported: Dryness, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae, miliaria
Uncommon (0.1% to 1%): Application site pain
Frequency not reported: Burning, itching, irritation
Rare (less than 0.1%): Eye disorder
Postmarketing reports: cataracts, glaucoma, increased intraocular pressure, central serous chorioretinopathy
Frequency not reported: Hyperglycemia
Frequency not reported: Glucosuria
Rare (less than 0.1%): Rebound effect
June 26, 2020
June 25, 2020
June 27, 2020
July 10, 2020
July 9, 2020
July 1, 2020